79324344 - HUB ORGANOIDS

Information

• Trademark
• 79324344

• Source

• Serial Number

  79324344

• Registration Number

  6909088

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  April 29, 2021
  4 years ago

• Registration Date

  November 29, 2022
  2 years ago

• Transaction Date

  January 10, 2025
  4 months ago

• Status Date

  November 29, 2022
  2 years ago

• Published for Opposition Date

  September 13, 2022
  2 years ago

• Location Date

  March 31, 2023
  2 years ago

• Status Code

  700

• Current Location

  TMO LAW OFFICE 111

  Employee Name

  SEVERSON, JUSTIN

• Attorney Docket Number

  2078154-0006

  Law Office Assigned Location Code

  M20

• Owners

  • Stichting Hubrecht Organoid Technology

Case File Statements

• DM0000: The mark consists of a stylised representation of an organoid in blue outline to the left of the term "HUB" in blue and "ORGANOIDS" in black. The colour white represents background and/or transparent areas and is not claimed as a feature of the mark.
• B00001: In the statement, line 9," cell culture reagents for scientific and research use" should be deleted.
• GS0051: Cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; stem cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; stem cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; epithelial cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; epithelial cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cell cultures for medical and veterinary research, diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cell cultures for medical and veterinary research, diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; diagnostic and analytical preparations for medical purposes; chemicals for use in scientific medical research for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; chemicals for use in scientific medical research for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; culture media for medical and veterinary use, namely, for use in diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; culture media for medical and veterinary use, namely, for use in diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; biological tissue cultures for medical and veterinary purposes; assays and assay preparations for medical and veterinary diagnostic testing of cells, cultures and organoids for therapeutic purposes; pharmaceutical and veterinary preparations and substances for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx
• CC0000: The color(s) blue and black is/are claimed as a feature of the mark.
• GS0011: Cells, stem cells, epithelial cells, all for scientific research purposes; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures, for scientific and research use; cell culture reagents for scientific and research use; cell culture media for scientific and research use; diagnostic and analytical preparations for use in science; chemicals used in science and industry; assays and assay preparations for scientific purposes; cell culture media for scientific research purposes
• GS0441: Medical services and surgery; medical and surgical diagnostic services; medical services in the nature of cell transplantation services
• DS0000: "ORGANOIDS"
• GS0421: Scientific research; genetic testing for scientific research purposes; medical and pharmacological research services; pharmaceutical drug and vaccine development services; development of pharmaceutical preparations and medicines; medical compound, drug and vaccine discovery, development services, and characterization and validation services in the nature of product quality and efficacy testing for medical compounds, drugs and vaccines; candidate drug and vaccine testing services, namely, testing of pharmaceuticals; compound, drug and vaccine testing services; companion diagnostics, namely, the scientific testing and evaluation of drugs and vaccines for individuals or groups of patients to determine the safety and effectiveness of the drug or vaccine for those patients; food safety testing services; testing of compounds and substances to determine toxicity to cells and organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures; scientific research and diagnostic services in the field of personalized medicine

Case File Event Statements

• 11/4/2021 - 3 years ago

  2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI

• 10/28/2021 - 3 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 11/5/2021 - 3 years ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/9/2021 - 3 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 12/18/2021 - 3 years ago

  5 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 12/29/2021 - 3 years ago

  6 - ASSIGNED TO EXAMINER Type: DOCK

• 1/13/2022 - 3 years ago

  7 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/28/2022 - 3 years ago

  11 - REFUSAL PROCESSED BY IB Type: RFNT

• 1/14/2022 - 3 years ago

  8 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 2/4/2022 - 3 years ago

  9 - REFUSAL PROCESSED BY MPU Type: RFRR

• 2/4/2022 - 3 years ago

  10 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 7/14/2022 - 2 years ago

  12 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 7/14/2022 - 2 years ago

  13 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 7/14/2022 - 2 years ago

  14 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 7/14/2022 - 2 years ago

  15 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 7/14/2022 - 2 years ago

  16 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 8/1/2022 - 2 years ago

  17 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 8/1/2022 - 2 years ago

  18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/1/2022 - 2 years ago

  19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/9/2022 - 2 years ago

  20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/24/2022 - 2 years ago

  21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 9/7/2022 - 2 years ago

  22 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 9/7/2022 - 2 years ago

  23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 9/13/2022 - 2 years ago

  24 - PUBLISHED FOR OPPOSITION Type: PUBO

• 9/13/2022 - 2 years ago

  25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 9/27/2022 - 2 years ago

  26 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 11/29/2022 - 2 years ago

  27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 11/29/2022 - 2 years ago

  28 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 12/19/2022 - 2 years ago

  29 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R

• 2/28/2023 - 2 years ago

  30 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 3/23/2023 - 2 years ago

  31 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 3/23/2023 - 2 years ago

  32 - POST REGISTRATION ACTION MAILED - SEC. 7 Type: PRAM

• 3/23/2023 - 2 years ago

  33 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP

• 3/31/2023 - 2 years ago

  34 - POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED Type: PRAN

• 3/31/2023 - 2 years ago

  35 - CORRECTION UNDER SECTION 7 - PROCESSED Type: COC.

• 4/17/2023 - 2 years ago

  36 - FINAL DISPOSITION PROCESSED Type: FIMP

• 4/17/2023 - 2 years ago

  37 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 5/9/2023 - 2 years ago

  38 - NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED Type: NURC

• 12/17/2023 - a year ago

  40 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR

• 4/5/2024 - a year ago

  42 - CHANGE OF OWNER RECEIVED FROM IB Type: CHLD

• 5/9/2023 - 2 years ago

  39 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 1/4/2024 - a year ago

  41 - INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Type: INNA

• 5/7/2024 - a year ago

  43 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH